The future of cancer prevention: Will our workforce be ready?

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 9, 2009, Pages 2348-2351

  Chang, Shine ^a   Collie, Candice L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER CONTROL; CANCER MORTALITY; CANCER PREVENTION; CLINICAL PRACTICE; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEART DISEASE; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL SOCIETY; PRIORITY JOURNAL; RADIATION EXPOSURE; SHORT SURVEY;

HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PUBLIC HEALTH;

EID: 70349326646     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0664     Document Type: Short Survey

References (14)

1. World Health Organization and International Agency for Research on Cancer. Boyle P, Levin B, editors. World cancer report 2008 [cited 2009 Jul 1]. Available from: http://www.who.int/publications/en/.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249
3. Cooper RA. The medical oncology workforce: an economic and demographic assessment of the demand for medical oncologists and hematologist-oncologists to serve the adult population to the year 2020 [Internet; cited 2009 Jul 1]. Available from: http://www.asco.org/ascov2/Practice+&+Guidelines/ Workforce+Initiatives.
4. Oncology Nursing Society. The impact of the national nursing shortage on quality cancer care. Oncology Nursing Forum 2007;34:1095-1096
5. Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M. Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Prat 2007;3:79-86. (Pubitemid 351593695)
6. American Society of Clinical Oncology. ASCO's workforce strategic plan 2008 [Internet; cited 2009 Jul 1]. Available from: http://www.asco.org/ascov2/ Practice+&+Guidelines/Workforce+Initiatives.
7. Anand P, Kunnumakara A, Sundaram C, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008;25:2097-2116
8. Ondrey F. Peroxisome proliferator-activated receptor γ pathway targeting in carcinogenesis: implications for chemoprevention. Clin Cancer Res 2009;1:2-8.
9. Richard CL, Blay J. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor γ-dependent manner. Int J Oncol 2007;30:1215-1222
10. Chang S, Hursting SD, Perkins SN, Dores GM, Weed DL. Adapting postdoctoral training to interdisciplinary science in the 21st century: the Cancer Prevention Fellowship Program at the National Cancer Institute. Acad Med 2005;80:261-265 (Pubitemid 40316120)
11. St. Jude Children's Research Hospital. Faculty positions. Cancer Epidemiol Biomarkers Prev 2007;16:185-364.
12. National Cancer Institute. Cancer education and career development program (R25) program announcement 2006 [Internet; cited 2009 Jul 1]. Available from: http://grants.nih.gov/grants/guide/pa-files/PAR-06-511.html.
13. National Cancer Institute. The Center for Cancer Training funding opportunities for training by award type 2009 [Internet; cited 2009 Jul 1]. Available from: http://www.cancer.gov/researchandfunding/cancertraining/ outsidenci/awardtype.
14. Buist DS, Kanetsky PA, Studts JL, et al. Recruiting and training leadership through professional societies: a report from the American Society of Preventive Oncology Junior Members Interest Group. Cancer Epidemiol Biomarkers Prev 2006;15:1422-1424